Livagen is a short bioregulatory peptide that has direct effects on DNA structure and function. It is best known for its ability to

decondense chromatin, thereby increasing the expression of certain genes and improving the “youthful” profile of cells. Its

most studied effects are on lymphocytes of the immune system. Through these cells, Livagen has been shown to activate the

immune system and offset disease in the heart, Gl tract, immune system, and central nervous system. Livagen research has

also shown promise in the area of nociception and pain control. Ongoing research will help to further unravel the promise of

Livagen and bring humanity closer to understanding the processes of aging and senescence.